Position in XGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$242,181
-$122,121 QoQ
Shares Held
52,082
-57.1% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 57 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $7,059,039,871 across 32 Diagnostics & Research names. XGN ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,957,066 | $1,482,554,608 | |
| 2 | DHR |
Danaher Corp /De/
|
5,364,861 | $1,021,898,721 | |
| 3 | A |
Agilent Technologies, Inc.
|
4,707,720 | $625,326,445 | |
| 4 | GH |
Guardant Health, Inc.
|
3,775,895 | $566,497,524 | |
| 5 | NTRA |
Natera, Inc.
|
1,720,152 | $466,935,259 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
738,708 | $388,885,438 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
1,949,797 | $376,739,772 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
252,137 | $322,107,537 |
All Filings in XGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,181 | 52,082 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $364,302 | 121,434 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $496,273 | 81,624 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $679,390 | 61,819 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $157,761 | 22,602 | Shares | Defined | 2025-08-14 | |
| 2021-12-31 | $124,882 | 10,738 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $144,608 | 10,633 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $152,733 | 10,189 | Shares | Defined | 2021-08-13 | |
| 2020-06-30 | $2,382,446 | 191,978 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||